CIP
Champlain Investment Partners’s Tandem Diabetes Care TNDM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $27.1M | Buy |
1,455,123
+86,235
| +6% | +$1.61M | 0.19% | 128 |
|
2025
Q1 | $26.2M | Sell |
1,368,888
-10,975
| -0.8% | -$210K | 0.19% | 135 |
|
2024
Q4 | $49.7M | Sell |
1,379,863
-89,298
| -6% | -$3.22M | 0.31% | 110 |
|
2024
Q3 | $62.3M | Sell |
1,469,161
-160,366
| -10% | -$6.8M | 0.38% | 95 |
|
2024
Q2 | $65.7M | Buy |
1,629,527
+115,970
| +8% | +$4.67M | 0.4% | 95 |
|
2024
Q1 | $53.6M | Sell |
1,513,557
-16,275
| -1% | -$576K | 0.31% | 105 |
|
2023
Q4 | $45.3M | Sell |
1,529,832
-86,047
| -5% | -$2.55M | 0.27% | 111 |
|
2023
Q3 | $33.6M | Sell |
1,615,879
-2,841
| -0.2% | -$59K | 0.22% | 118 |
|
2023
Q2 | $39.7M | Sell |
1,618,720
-1,654,393
| -51% | -$40.6M | 0.24% | 112 |
|
2023
Q1 | $133M | Buy |
3,273,113
+204,250
| +7% | +$8.29M | 0.84% | 49 |
|
2022
Q4 | $138M | Sell |
3,068,863
-55,110
| -2% | -$2.48M | 0.88% | 45 |
|
2022
Q3 | $149M | Buy |
3,123,973
+484,310
| +18% | +$23.2M | 1.02% | 31 |
|
2022
Q2 | $156M | Buy |
2,639,663
+1,098,338
| +71% | +$65M | 1.01% | 35 |
|
2022
Q1 | $179M | Buy |
1,541,325
+54,812
| +4% | +$6.37M | 0.93% | 42 |
|
2021
Q4 | $224M | Sell |
1,486,513
-7,325
| -0.5% | -$1.1M | 1.01% | 31 |
|
2021
Q3 | $178M | Sell |
1,493,838
-52,732
| -3% | -$6.3M | 0.85% | 46 |
|
2021
Q2 | $151M | Buy |
1,546,570
+204,410
| +15% | +$19.9M | 0.72% | 58 |
|
2021
Q1 | $118M | Buy |
+1,342,160
| New | +$118M | 0.62% | 74 |
|